查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1504935

全球罕见疾病诊断市场，占有率，规模，趋势，产业分析报告:各疾病类型，各产品类型，各样品类型，各技术，试验，各年龄层，各特性类型，各终端用户，各地区，市场区隔预测，2024年-2032年

Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024 - 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，到2032年，全球罕见疾病诊断市场规模预计将达到889.6927亿美元。该研究报告提供了对当前市场动态的详细洞察，并对未来市场成长进行了分析。

在技术快速进步和规模经济推动下基因组定序的可用性和价格不断提高等创新的推动下，罕见疾病诊断市场正在经历强劲增长。随着定序成本的持续下降和分析速度的提高，基因组测试将变得更加广泛，使医疗保健提供者能够为疑似罕见疾病患者提供全面的基因评估。

然而，这需要发现和验证专门用于识别罕见疾病的新测试方法、生物标记和技术。研发投资推动创新，并能开发出更准确、更有效率、更具成本效益的测试解决方案。学术界、製药公司和生技公司之间的合作对于增进科学理解并将发现转化为实用的诊断工具至关重要。

罕见疾病治疗和诊断工具的市场规模有限也导致了成本高昂。医疗保健组织、政策制定者和医疗利益相关者努力提高对罕见疾病经济负担的认识，并采取措施改善我所受影响的人获得负担得起的诊断测试和治疗的机会。此外，技术进步和合作研究措施预计将在未来降低罕见疾病诊断的成本并提高效率。

全球罕见疾病诊断市场报告亮点

血液学和肿瘤学领域因其能够准确、快速地检测罕见的血液学和肿瘤学疾病而占据市场主导地位，从而实现早期干预和量身定制的治疗方法。

由于罕见疾病检测技术的进步可实现快速、准确的诊断，试剂盒和试剂行业预计将主导市场，并以最快的复合年增长率增长。

市场区隔凭藉最先进的基础设施、先进的技术和熟练的诊断人员主导着市场。

由于对能够准确识别和诊断罕见疾病的专业诊断服务的需求不断增长，诊断实验室行业预计将在预期期间表现出最高的复合年增长率。

由于基因检测和精准医学的进步，北美在该行业处于领先地位，并占据了大部分市场收入占有率，这在罕见疾病的诊断和治疗中发挥关键作用。

目录

第1章 简介

第2章 利害关係者

第3章 摘要整理

第4章 调查手法

第5章 全球罕见疾病诊断市场洞察

  • 罕见疾病诊断-产业概述
  • 罕见疾病诊断市场动态
    • 促进因素和机会
      • 基因体技术的进步推动诊断创新
      • 由于认识提高，诊断需求增加
    • 阻碍因素与课题
      • 高成本
  • PESTEL分析
  • 罕见疾病诊断产业
  • 价值链分析
  • COVID-19影响分析

第6章 全球罕见疾病诊断市场:各疾病类型

  • 主要调查结果
  • 简介
  • 消化器官疾病
  • 内分泌及代谢障碍
  • 心血管疾病
  • 肌肉骨骼障碍
  • 神经疾病
  • 血液学及肿瘤学疾病
  • 皮肤科疾病
  • 其他

第7章 全球罕见疾病诊断市场:各产品类型

  • 主要调查结果
  • 简介
  • 套件和试剂
  • 设备
  • 软体

第8章 全球罕见疾病诊断市场:各样品类型

  • 主要调查结果
  • 简介
  • 血液样品
  • 颊黏膜拭子样本
  • 其他

第9章 全球罕见疾病诊断市场:各技术

  • 主要调查结果
  • 简介
  • 次世代定序
  • 全EXOME
  • 全基因
  • 阵列科技
  • PCR为基础的检验
  • FISH
  • Sanger序列
  • 染色体组型分析

第10章 全球罕见疾病诊断市场:检查别

  • 主要调查结果
  • 简介
  • 遗传基因检验
  • 一般的临床检验
  • 影像检查

第11章 全球罕见疾病诊断市场: 各年龄层

  • 主要调查结果
  • 简介
  • 大人
  • 儿童

第12章 全球罕见疾病诊断市场:各特性类型

  • 主要调查结果
  • 简介
  • 遗传性
  • 后天性

第13章 全球罕见疾病诊断市场:各最终用途

  • 主要调查结果
  • 简介
  • 调查机关和CRO
  • 医院·诊所
  • 诊断检验室

第14章 全球罕见疾病诊断市场:地区

  • 主要调查结果
  • 简介
    • 罕见疾病诊断市场评估:地区，2019年～2032年
  • 北美
    • 北美:各疾病类型，2019年～2032年
    • 北美:各技术，2019年～2032年
    • 北美:各产品类型，2019年～2032年
    • 北美:试验，2019年～2032年
    • 北美:各样品类型，2019年～2032年
    • 北美:各年龄层，2019年～2032年
    • 北美:各特性类型，2019年～2032年
    • 美国
    • 加拿大
  • 欧洲
    • 欧洲:各疾病类型，2019年～2032年
    • 欧洲:各技术，2019年～2032年
    • 欧洲:各产品类型，2019年～2032年
    • 欧洲:试验，2019年～2032年
    • 欧洲:各样品类型，2019年～2032年
    • 欧洲:各年龄层，2019年～2032年
    • 欧洲:各特性类型，2019年～2032年
    • 英国
    • 法国
    • 德国
    • 义大利
    • 西班牙
    • 荷兰
    • 俄罗斯
  • 亚太地区
    • 亚太地区:各疾病类型，2019年～2032年
    • 亚太地区:各技术，2019年～2032年
    • 亚太地区:各产品类型，2019年～2032年
    • 亚太地区:试验，2019年～2032年
    • 亚太地区:各样品类型，2019年～2032年
    • 亚太地区:各年龄层，2019年～2032年
    • 亚太地区:各特性类型，2019年～2032年
    • 中国
    • 印度
    • 日本
    • 马来西亚
    • 印尼
    • 韩国
  • 中东·非洲
    • 中东及非洲:各疾病类型，2019年～2032年
    • 中东·非洲:各技术，2019年～2032年
    • 中东及非洲:各产品类型，2019年～2032年
    • 中东及非洲:试验，2019年～2032年
    • 中东及非洲:各样品类型，2019年～2032年
    • 中东·非洲:各年龄层，2019年～2032年
    • 中东及非洲:各特性类型，2019年～2032年
    • 沙乌地阿拉伯
    • 阿拉伯联合大公国
    • 以色列
    • 南非
  • 南美
    • 南美:各疾病类型，2019年～2032年
    • 南美:各技术，2019年～2032年
    • 南美:各产品类型，2019年～2032年
    • 南美:试验，2019年～2032年
    • 南美:各样品类型，2019年～2032年
    • 南美:各年龄层，2019年～2032年
    • 南美:各特性类型，2019年～2032年
    • 墨西哥
    • 巴西
    • 阿根廷

第15章 竞争情形

  • 扩大和收购的分析
    • 扩大
    • 收购
  • 联盟/合作/协定/公开

第16章 企业简介

  • 3billion, Inc.
  • Agilent Technologies, Inc
  • CENTOGENE N.V
  • F. Hoffmann-La Roche Ltd
  • FDNA(TM)INC
  • GeneDx, LLC
  • Illumina, Inc.
  • Invitae Corporation
  • Novo Nordisk A/S
  • Quest Diagnostics
Product Code: PM4902

The global rare disease diagnostics market size is expected to reach USD 88,969.27 million by 2032, according to a new study by Polaris Market Research. The report "Global Rare Disease Diagnostics Market Share, Size, Trends, Industry Analysis Report, By Disease Type; By Product Type; By Sample Type; By Technology; By Test; By Age Group; By Trait Type; By End-User; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The rare disease diagnostics market is experiencing robust growth, driven by innovation is the increasing accessibility and affordability of genomic sequencing, facilitated by rapid technological advancements and economies of scale. As the cost of sequencing continues to decline and the speed of analysis improves, genomic testing has become more widely available, enabling healthcare providers to offer comprehensive genetic evaluations to patients with suspected rare diseases.

However, this involves the discovery and validation of novel testing methods, biomarkers, and technologies tailored for identifying rare diseases. Investments in R&D drive innovation, enabling the development of more accurate, efficient, and cost-effective testing solutions. Collaboration between academia, pharmaceutical companies, and biotech firms is crucial in advancing scientific understanding and translating discoveries into practical diagnostic tools.

The limited market size for treatments and diagnostic tools targeting rare diseases also contributes to their high cost. Advocacy organizations, policymakers, and healthcare stakeholders are working to raise awareness of the economic burden of rare diseases and implement measures to improve access to affordable diagnostic testing and treatments for affected individuals. Additionally, advancements in technology and collaborative research initiatives hold promise for driving down costs and improving the efficiency of rare disease diagnosis in the future.

Global Rare Disease Diagnostics Market Report Highlights

The Hematology and Oncology disease segment dominated the market owing to the precise and prompt detection of rare blood and oncological conditions, which led to early intervention and tailored treatment approaches.

The Kits and Reagents segment dominated and is anticipated to grow at the fastest CAGR owing to advancements in the detection of rare diseases, which enable quicker and more precise diagnosis.

The Research Laboratories and Cros segment dominated the market owing to cutting-edge infrastructure, advanced technologies, and skilled personnel for diagnostic purposes.

The Diagnostics Laboratories segment is expected to witness the highest CAGR over the anticipated period due to a rise in demand for specialized diagnostic services that can accurately identify and diagnose rare diseases.

North America led the industry and accounted for a majority of market revenue share owing to the progress made in genetic testing and precision medicine, which play crucial roles in diagnosing and treating rare conditions.

The global key market players include CENTOGENE N.V., F. Hoffmann-La Roche Ltd., FDNA(TM) INC, GeneDx, LLC, Illumina, Inc., Invitae Corporation, Novo Nordisk A/S, Quest Diagnostics, etc.

Polaris Market Research has segmented the global rare disease diagnostics market report based on disease type, product type, sample type, technology, test, age group, trait type, end-user, and region:

Global Rare Disease Diagnostics, Disease Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Gastroenterology Disease
  • Endocrine and Metabolism Disorders Disease
  • Cardiovascular Disorders
  • Musculoskeletal Disorders
  • Neurology Disease
  • Hematology and Oncology Disease
  • Dermatology Disease
  • Others

Global Rare Disease Diagnostics, Product Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Kits & Reagents
  • Instruments
  • Software

Global Rare Disease Diagnostics, Sample Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Blood Sample
  • Buccal Swab Sample
  • Others

Global Rare Disease Diagnostics, Technology Outlook (Revenue - USD Billion, 2019 - 2032)

  • Next Generation Sequencing
  • Whole Exome
  • Whole Genome
  • Array Technology
  • PCR Based Testing
  • FISH
  • Sanger Sequencing
  • Karyotyping

Global Rare Disease Diagnostics, Test Outlook (Revenue - USD Million, 2019 - 2032)

  • Genetic Test
  • General Lab Test
  • Imaging Test

Global Rare Disease Diagnostics, Age Group Outlook (Revenue - USD Million, 2019 - 2032)

  • Children
  • Adult

Global Rare Disease Diagnostics, Trait Type Outlook (Revenue - USD Million, 2019 - 2032)

  • Inherited
  • Acquired

Global Rare Disease Diagnostics, End- Use Outlook (Revenue - USD Million, 2019 - 2032)

  • Research Laboratories & Cros
  • Hospitals & Clinics
  • Diagnostic Laboratories

Global Rare Disease Diagnostics, Regional Outlook (Revenue - USD Million, 2019 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Australia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions

2. Stakeholders

3. Executive Summary

  • 3.1. Market Highlights

4. Research Methodology

  • 4.1. Overview
    • 4.1.1. Data Mining
  • 4.2. Data Sources
    • 4.2.1. Primary Sources
    • 4.2.2. Secondary Sources

5. Global Rare Disease Diagnostics Market Insights

  • 5.1. Rare Disease Diagnostics - Industry Snapshot
  • 5.2. Rare Disease Diagnostics Market Dynamics
    • 5.2.1. Drivers and Opportunities
      • 5.2.1.1. Advances in genomic technologies drive diagnostic innovation
      • 5.2.1.2. Increasing awareness leads to higher demand for diagnostics
    • 5.2.2. Restraints and Challenges
      • 5.2.2.1. High costs
    • 5.2.3. Porter's Five Forces Analysis
      • 5.2.3.1. Bargaining Power of Suppliers (Moderate)
      • 5.2.3.2. Threats of New Entrants (Low)
      • 5.2.3.3. Bargaining Power of Buyers (Moderate)
      • 5.2.3.4. Threat of Substitute (Moderate)
      • 5.2.3.5. Rivalry among Existing Firms (High)
  • 5.3. PESTEL Analysis
  • 5.4. Rare Disease Diagnostics Industry
  • 5.5. Value Chain Analysis
  • 5.6. COVID-19 Impact Analysis

6. Global Rare Disease Diagnostics Market, by Disease Type

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • 6.3. Gastroenterology Disease
    • 6.3.1. Global Rare Disease Diagnostics Market, by Gastroenterology Disease, by Region, 2019-2032 (USD Million)
  • 6.4. Endocrine and Metabolism Disorders Disease
    • 6.4.1. Global Rare Disease Diagnostics Market, by Endocrine and Metabolism Disorders Disease, by Region, 2019-2032 (USD Million)
  • 6.5. Cardiovascular Disorders
    • 6.5.1. Global Rare Disease Diagnostics Market, by Cardiovascular Disorders, by Region, 2019-2032 (USD Million)
  • 6.6. Musculoskeletal Disorders
    • 6.6.1. Global Rare Disease Diagnostics Market, by Musculoskeletal Disorders, by Region, 2019-2032 (USD Million)
  • 6.7. Neurology Disease
    • 6.7.1. Global Rare Disease Diagnostics Market, by Neurology Disease, by Region, 2019-2032 (USD Million)
  • 6.8. Hematology and Oncology Disease
    • 6.8.1. Global Rare Disease Diagnostics Market, by Hematology and Oncology Disease, by Region, 2019-2032 (USD Million)
  • 6.9. Dermatology Disease
    • 6.9.1. Global Rare Disease Diagnostics Market, by Dermatology Disease, by Region, 2019-2032 (USD Million)
  • 6.10. Others
    • 6.10.1. Global Rare Disease Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Rare Disease Diagnostics Market, by Mode of Product Type

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • 7.3. Kits & Reagents
    • 7.3.1. Global Rare Disease Diagnostics Market, by Kits & Reagents, by Region, 2019-2032 (USD Million)
  • 7.4. Instruments
    • 7.4.1. Global Rare Disease Diagnostics Market, by Instruments, by Region, 2019-2032 (USD Million)
  • 7.5. Software
    • 7.5.1. Global Rare Disease Diagnostics Market, by Software, by Region, 2019-2032 (USD Million)

8. Global Rare Disease Diagnostics Market, by Sample Type

  • 8.1. Key Findings
  • 8.2. Introduction
    • 8.2.1. Global Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • 8.3. Blood Sample
    • 8.3.1. Global Rare Disease Diagnostics Market, by Blood Sample, by Region, 2019-2032 (USD Million)
  • 8.4. Buccal Swab Sample
    • 8.4.1. Global Rare Disease Diagnostics Market, by Buccal Swab Sample, by Region, 2019-2032 (USD Million)
  • 8.5. Others
    • 8.5.1. Global Rare Disease Diagnostics Market, by Others, by Region, 2019-2032 (USD Million)

9. Global Rare Disease Diagnostics Market, by Technology

  • 9.1. Key Findings
  • 9.2. Introduction
    • 9.2.1. Global Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • 9.3. Next Generation Sequencing
    • 9.3.1. Global Rare Disease Diagnostics Market, by Next Generation Sequencing, by Region, 2019-2032 (USD Million)
  • 9.4. Whole Exome
    • 9.4.1. Global Rare Disease Diagnostics Market, by Whole Exome, by Region, 2019-2032 (USD Million)
  • 9.5. Whole Genome
    • 9.5.1. Global Rare Disease Diagnostics Market, by Whole Genome, by Region, 2019-2032 (USD Million)
  • 9.6. Array Technology
    • 9.6.1. Global Rare Disease Diagnostics Market, by Array Technology, by Region, 2019-2032 (USD Million)
  • 9.7. PCR Based Testing
    • 9.7.1. Global Rare Disease Diagnostics Market, by PCR Based Testing, by Region, 2019-2032 (USD Million)
  • 9.8. FISH
    • 9.8.1. Global Rare Disease Diagnostics Market, by FISH, by Region, 2019-2032 (USD Million)
  • 9.9. Sanger Sequencing
    • 9.9.1. Global Rare Disease Diagnostics Market, by Sanger Sequencing, by Region, 2019-2032 (USD Million)
  • 9.10. Karyotyping
    • 9.10.1. Global Rare Disease Diagnostics Market, by Karyotyping, by Region, 2019-2032 (USD Million)

10. Global Rare Disease Diagnostics Market, by Test

  • 10.1. Key Findings
  • 10.2. Introduction
    • 10.2.1. Global Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • 10.3. Genetic Test
    • 10.3.1. Global Rare Disease Diagnostics Market, by Genetic Test, by Region, 2019-2032 (USD Million)
  • 10.4. General Lab Test
    • 10.4.1. Global Rare Disease Diagnostics Market, by General Lab Test, by Region, 2019-2032 (USD Million)
  • 10.5. Imaging Test
    • 10.5.1. Global Rare Disease Diagnostics Market, by Imaging Test, by Region, 2019-2032 (USD Million)

11. Global Rare Disease Diagnostics Market, by Age Group

  • 11.1. Key Findings
  • 11.2. Introduction
    • 11.2.1. Global Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • 11.3. Adult
    • 11.3.1. Global Rare Disease Diagnostics Market, by Adult, by Region, 2019-2032 (USD Million)
  • 11.4. Children
    • 11.4.1. Global Rare Disease Diagnostics Market, by Children, by Region, 2019-2032 (USD Million)

12. Global Rare Disease Diagnostics Market, by Trait Type

  • 12.1. Key Findings
  • 12.2. Introduction
    • 12.2.1. Global Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 12.3. Inherited
    • 12.3.1. Global Rare Disease Diagnostics Market, by Inherited, by Region, 2019-2032 (USD Million)
  • 12.4. Acquired
    • 12.4.1. Global Rare Disease Diagnostics Market, by Acquired, by Region, 2019-2032 (USD Million)

13. Global Rare Disease Diagnostics Market, by End-Use

  • 13.1. Key Findings
  • 13.2. Introduction
    • 13.2.1. Global Rare Disease Diagnostics Market, by End-Use, 2019-2032 (USD Million)
  • 13.3. Research Laboratories & CROs
    • 13.3.1. Global Rare Disease Diagnostics Market, by Research Laboratories & CROs, by Region, 2019-2032 (USD Million)
  • 13.4. Hospitals & Clinics
    • 13.4.1. Global Rare Disease Diagnostics Market, by Hospitals & Clinics, by Region, 2019-2032 (USD Million)
  • 13.5. Diagnostic Laboratories
    • 13.5.1. Global Rare Disease Diagnostics Market, by Diagnostic Laboratories, by Region, 2019-2032 (USD Million)

14. Global Rare Disease Diagnostics Market, by Geography

  • 14.1. Key Findings
  • 14.2. Introduction
    • 14.2.1. Rare Disease Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
  • 14.3. Rare Disease Diagnostics Market - North America
    • 14.3.1. North America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.3.2. North America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.3.3. North America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.3.4. North America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.3.5. North America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.3.6. North America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.3.7. North America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.3.8. Rare Disease Diagnostics Market - U.S.
      • 14.3.8.1. U.S.: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.3.8.2. U.S.: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.3.8.3. U.S.: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.3.8.4. U.S.: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.3.8.5. U.S.: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.3.8.6. U.S.: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.3.8.7. U.S.: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.3.9. Rare Disease Diagnostics Market - Canada
      • 14.3.9.1. Canada: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.3.9.2. Canada: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.3.9.3. Canada: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.3.9.4. Canada: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.3.9.5. Canada: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.3.9.6. Canada: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.3.9.7. Canada: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.4. Rare Disease Diagnostics Market - Europe
    • 14.4.1. Europe: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.4.2. Europe: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.4.3. Europe: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.4.4. Europe: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.4.5. Europe: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.4.6. Europe: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.4.7. Europe: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.8. Rare Disease Diagnostics Market - UK
      • 14.4.8.1. UK: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.8.2. UK: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.8.3. UK: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.8.4. UK: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.8.5. UK: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.8.6. UK: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.8.7. UK: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.9. Rare Disease Diagnostics Market - France
      • 14.4.9.1. France: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.9.2. France: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.9.3. France: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.9.4. France: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.9.5. France: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.9.6. France: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.9.7. France: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.10. Rare Disease Diagnostics Market - Germany
      • 14.4.10.1. Germany: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.10.2. Germany: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.10.3. Germany: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.10.4. Germany: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.10.5. Germany: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.10.6. Germany: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.10.7. Germany: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.11. Rare Disease Diagnostics Market - Italy
      • 14.4.11.1. Italy: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.11.2. Italy: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.11.3. Italy: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.11.4. Italy: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.11.5. Italy: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.11.6. Italy: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.11.7. Italy: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.12. Rare Disease Diagnostics Market - Spain
      • 14.4.12.1. Spain: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.12.2. Spain: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.12.3. Spain: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.12.4. Spain: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.12.5. Spain: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.12.6. Spain: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.12.7. Spain: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.13. Rare Disease Diagnostics Market - Netherlands
      • 14.4.13.1. Netherlands: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.13.2. Netherlands: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.13.3. Netherlands: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.13.4. Netherlands: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.13.5. Netherlands: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.13.6. Netherlands: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.13.7. Netherlands: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.4.14. Rare Disease Diagnostics Market - Russia
      • 14.4.14.1. Russia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.4.14.2. Russia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.4.14.3. Russia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.4.14.4. Russia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.4.14.5. Russia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.4.14.6. Russia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.4.14.7. Russia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.5. Rare Disease Diagnostics Market - Asia Pacific
    • 14.5.1. Asia Pacific: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.5.2. Asia Pacific: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.5.3. Asia Pacific: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.5.4. Asia Pacific: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.5.5. Asia Pacific: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.5.6. Asia Pacific: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.5.7. Asia Pacific: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.8. Rare Disease Diagnostics Market - China
      • 14.5.8.1. China: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.8.2. China: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.8.3. China: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.8.4. China: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.8.5. China: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.8.6. China: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.8.7. China: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.9. Rare Disease Diagnostics Market - India
      • 14.5.9.1. India: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.9.2. India: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.9.3. India: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.9.4. India: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.9.5. India: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.9.6. India: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.9.7. India: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.10. Rare Disease Diagnostics Market - Japan
      • 14.5.10.1. Japan: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.10.2. Japan: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.10.3. Japan: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.10.4. Japan: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.10.5. Japan: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.10.6. Japan: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.10.7. Japan: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.11. Rare Disease Diagnostics Market - Malaysia
      • 14.5.11.1. Malaysia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.11.2. Malaysia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.11.3. Malaysia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.11.4. Malaysia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.11.5. Malaysia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.11.6. Malaysia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.11.7. Malaysia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.12. Rare Disease Diagnostics Market - Indonesia
      • 14.5.12.1. Indonesia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.12.2. Indonesia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.12.3. Indonesia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.12.4. Indonesia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.12.5. Indonesia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.12.6. Indonesia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.12.7. Indonesia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.5.13. Rare Disease Diagnostics Market - South Korea
      • 14.5.13.1. South Korea: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.5.13.2. South Korea: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.5.13.3. South Korea: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.5.13.4. South Korea: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.5.13.5. South Korea: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.5.13.6. South Korea: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.5.13.7. South Korea: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.6. Rare Disease Diagnostics Market - Middle East & Africa
    • 14.6.1. Middle East & Africa: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.6.2. Middle East & Africa: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.6.3. Middle East & Africa: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.6.4. Middle East & Africa: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.6.5. Middle East & Africa: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.6.6. Middle East & Africa: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.6.7. Middle East & Africa: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.8. Rare Disease Diagnostics Market - Saudi Arabia
      • 14.6.8.1. Saudi Arabia: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.8.2. Saudi Arabia: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.8.3. Saudi Arabia: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.8.4. Saudi Arabia: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.8.5. Saudi Arabia: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.8.6. Saudi Arabia: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.8.7. Saudi Arabia: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.9. Rare Disease Diagnostics Market - UAE
      • 14.6.9.1. UAE: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.9.2. UAE: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.9.3. UAE: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.9.4. UAE: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.9.5. UAE: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.9.6. UAE: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.9.7. UAE: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.10. Rare Disease Diagnostics Market - Israel
      • 14.6.10.1. Israel: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.10.2. Israel: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.10.3. Israel: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.10.4. Israel: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.10.5. Israel: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.10.6. Israel: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.10.7. Israel: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.6.11. Rare Disease Diagnostics Market - South Africa
      • 14.6.11.1. South Africa: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.6.11.2. South Africa: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.6.11.3. South Africa: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.6.11.4. South Africa: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.6.11.5. South Africa: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.6.11.6. South Africa: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.6.11.7. South Africa: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • 14.7. Rare Disease Diagnostics Market - Latin America
    • 14.7.1. Latin America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
    • 14.7.2. Latin America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
    • 14.7.3. Latin America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
    • 14.7.4. Latin America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
    • 14.7.5. Latin America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
    • 14.7.6. Latin America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
    • 14.7.7. Latin America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.8. Rare Disease Diagnostics Market - Mexico
      • 14.7.8.1. Mexico: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.8.2. Mexico: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.8.3. Mexico: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.8.4. Mexico: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.8.5. Mexico: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.8.6. Mexico: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.8.7. Mexico: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.9. Rare Disease Diagnostics Market - Brazil
      • 14.7.9.1. Brazil: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.9.2. Brazil: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.9.3. Brazil: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.9.4. Brazil: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.9.5. Brazil: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.9.6. Brazil: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.9.7. Brazil: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
    • 14.7.10. Rare Disease Diagnostics Market - Argentina
      • 14.7.10.1. Argentina: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
      • 14.7.10.2. Argentina: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
      • 14.7.10.3. Argentina: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
      • 14.7.10.4. Argentina: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
      • 14.7.10.5. Argentina: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
      • 14.7.10.6. Argentina: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
      • 14.7.10.7. Argentina: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)

15. Competitive Landscape

  • 15.1. Expansion and Acquisition Analysis
    • 15.1.1. Expansion
    • 15.1.2. Acquisitions
  • 15.2. Partnerships/Collaborations/Agreements/Exhibitions

16. Company Profiles

  • 16.1. 3billion, Inc.
    • 16.1.1. Company Overview
    • 16.1.2. Financial Performance
    • 16.1.3. Product Benchmarking
    • 16.1.4. Recent Development
  • 16.2. Agilent Technologies, Inc
    • 16.2.1. Company Overview
    • 16.2.2. Financial Performance
    • 16.2.3. Product Benchmarking
    • 16.2.4. Recent Development
  • 16.3. CENTOGENE N.V
    • 16.3.1. Company Overview
    • 16.3.2. Financial Performance
    • 16.3.3. Product Benchmarking
    • 16.3.4. Recent Development
  • 16.4. F. Hoffmann-La Roche Ltd
    • 16.4.1. Company Overview
    • 16.4.2. Financial Performance
    • 16.4.3. Product Benchmarking
    • 16.4.4. Recent Development
  • 16.5. FDNA(TM) INC
    • 16.5.1. Company Overview
    • 16.5.2. Financial Performance
    • 16.5.3. Product Benchmarking
    • 16.5.4. Recent Development
  • 16.6. GeneDx, LLC
    • 16.6.1. Company Overview
    • 16.6.2. Financial Performance
    • 16.6.3. Product Benchmarking
    • 16.6.4. Recent Development
  • 16.7. Illumina, Inc.
    • 16.7.1. Company Overview
    • 16.7.2. Financial Performance
    • 16.7.3. Product Benchmarking
    • 16.7.4. Recent Development
  • 16.8. Invitae Corporation
    • 16.8.1. Company Overview
    • 16.8.2. Financial Performance
    • 16.8.3. Product Benchmarking
    • 16.8.4. Recent Development
  • 16.9. Novo Nordisk A/S
    • 16.9.1. Company Overview
    • 16.9.2. Financial Performance
    • 16.9.3. Product Benchmarking
    • 16.9.4. Recent Development
  • 16.10. Quest Diagnostics
    • 16.10.1. Company Overview
    • 16.10.2. Financial Performance
    • 16.10.3. Product Benchmarking
    • 16.10.4. Recent Development

List of Tables

  • Table 1 Global Rare Disease Diagnostics Market, by Disease Type, by Region, 2019-2032 (USD Million)
  • Table 2 Global Rare Disease Diagnostics Market, by Technology, by Region, 2019-2032 (USD Million)
  • Table 3 Global Rare Disease Diagnostics Market, by Mode of Product Type, by Region, 2019-2032 (USD Million)
  • Table 4 Global Rare Disease Diagnostics Market, by Test, by Region, 2019-2032 (USD Million)
  • Table 5 Global Rare Disease Diagnostics Market, by Sample Type, by Region, 2019-2032 (USD Million)
  • Table 6 Global Rare Disease Diagnostics Market, by Age Group, by Region, 2019-2032 (USD Million)
  • Table 7 Global Rare Disease Diagnostics Market, by Trait Type, by Region, 2019-2032 (USD Million)
  • Table 8 Rare Disease Diagnostics Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 9 North America: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • Table 10 North America: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 11 North America: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)
  • Table 12 North America: Rare Disease Diagnostics Market, by Test, 2019-2032 (USD Million)
  • Table 13 North America: Rare Disease Diagnostics Market, by Sample Type, 2019-2032 (USD Million)
  • Table 14 North America: Rare Disease Diagnostics Market, by Age Group, 2019-2032 (USD Million)
  • Table 15 North America: Rare Disease Diagnostics Market, by Trait Type, 2019-2032 (USD Million)
  • Table 16 U.S.: Rare Disease Diagnostics Market, by Disease Type, 2019-2032 (USD Million)
  • Table 17 U.S.: Rare Disease Diagnostics Market, by Technology, 2019-2032 (USD Million)
  • Table 18 U.S.: Rare Disease Diagnostics Market, by Mode of Product Type, 2019-2032 (USD Million)